Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Health Tech channel feed
23andMe files for bankruptcy, CEO Wojcicki steps down
2 months ago
Financing
Google is building AI healthcare helpers
2 months ago
Like its rivals, Optum Rx is changing its payment models
2 months ago
A California health tech company is letting AI run medical visits, from intake to diagnosis
2 months ago
AI
In Focus
Exclusive: Foodsmart names former Amwell executive as its new CEO
2 months ago
People
With Hinge Health filing to go public, are we... back?
2 months ago
Inside NYC’s waitlist-only health tech club, where young professionals find both friends and jobs
2 months ago
In Focus
Endpoints wins SABEW 'Best in Business' award for Health Tech coverage and newsletter
2 months ago
Editor's note
The new CEO of GoodRx wants to lean into brand names and speed up the drug discount company's growth
2 months ago
Walgreens turns on dark mode
2 months ago
Exclusive: Define Ventures hires former Aetion CEO Carolyn Magill
2 months ago
People
Virtual physical therapy startup Hinge Health files to go public
2 months ago
Compounders’ motion for preliminary injunction denied in case over tirzepatide shortage
2 months ago
Pharma
Law
Walgreens to go private in $10B deal
2 months ago
Deals
Healthcare is bullish on AI
2 months ago
Teladoc holds out for 2026
2 months ago
UnitedHealthcare’s copay-only plan is booming, despite backlash over care denials
2 months ago
23andMe rejects CEO's second take-private offer
2 months ago
Cerebral CEO David Mou has stepped down
2 months ago
People
OpenAI meets cancer care
2 months ago
Teladoc reports $1B net loss as it works to turn around its business
2 months ago
Is the GLP-1 compounding boom over? Not exactly
2 months ago
Hims eyes growth in its weight loss business, despite end of semaglutide shortage
2 months ago
Pharma
23andMe's CEO submits bid to take company private for $74.7M
2 months ago
Financing
First page
Previous page
1
2
3
4
5
6
Next page
Last page